Lymerix Two-Month Dose Expected By Mid-2000, Pediatric Data By Year-End
Executive Summary
SmithKline Beecham's Lymerix two-month accelerated dosing regimen could receive FDA approval in the first half of 2000, Jean-Pierre Garnier, PhD, said Sept. 16 at the Bear Stearns health care conference in New York City.